Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Alginic acid** is a naturally derived, heterogeneous anionic polysaccharide isolated primarily from brown seaweed. It is composed of variably arranged mannuronic-acid and guluronic-acid residues and hydrates to form viscous gels. In oral reflux products, alginic-acid or alginate-containing formulations can form a buoyant, viscous barrier over gastric contents, reducing physical reflux into the esophagus and laryngopharynx; this is a local, non-systemic physical mechanism rather than receptor-mediated pharmacology. The exact acid polymer should not be conflated with its chemically distinct sodium, calcium, potassium, or mixed alginate salts, which are commonly used in commercial and investigational formulations. Alginic acid has also been investigated as a soluble dietary fiber for effects on satiety, fat digestion, and the intestinal microbiome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alginic acid.